BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Hemispherx Biopharma Inc. 

One Penn Center
1617 JFK Boulevard
Philadelphia  Pennsylvania  19103  U.S.A.
Phone: 215-988-0080 Fax: 215-988-1739


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Hemispherx Biopharma (HEB) Announces Financial Results For The Six Months Ended June 30, 2014 8/11/2014 7:45:33 AM
Hemispherx Biopharma (HEB)'s Two Drugs, Ampligen® And Alferon® Ranked Highly In Sensitivity Testing Against MERS/SARS Coronaviruses 8/4/2014 8:24:03 AM
Hemispherx Biopharma (HEB) Achieves High Ranking In Sensitivity Testing Against MERS/SARS Coronaviruses Compared To Other Drugs 7/22/2014 3:36:24 PM
Hemispherx Biopharma (HEB) And Bioclones, A Leading South African Biotechnology Company, Join Forces On Novel Therapeutic Cancer Vaccine 7/14/2014 7:58:45 AM
Hemispherx Biopharma (HEB) And Bioclones Join Forces In Effort To Eradicate HIV/AIDS Virus Based On Recent Clinical Insights Of Wistar Institute, University of Pennsylvania 7/8/2014 10:39:00 AM
Hemispherx Biopharma (HEB) To Present During The 2014 Biotechnology Industry Organization (BIO) International Convention June 26 6/25/2014 8:00:13 AM
Hemispherx Biopharma (HEB) Announces New Publication With Potential Insight Into High Mortality Rate In Middle Eastern Respiratory Syndrome (MERS) 6/16/2014 7:54:51 AM
Hemispherx Biopharma (HEB) Announces That The University of Texas Medical Branch Confirms Activity Of Alferon® N Against MERS (Middle East Respiratory Syndrome) Virus 6/4/2014 9:09:04 AM
Hemispherx Biopharma (HEB) Receives New U.S. Composition Of Matter Patent Covering Ampligen® Formulations 5/27/2014 8:58:23 AM
Hemispherx Biopharma (HEB) And GP Pharm Agree To Establish A Manufacturing Operation In Argentina To Serve Latin America Markets And Ancillary Markets 5/21/2014 9:25:30 AM
12345678910...